Department of Internal Medicine, Division of Gastroenterology, East Tennessee State University, Johnson City, TN.
Department of Internal Medicine, Saint Peter's University Hospital, New Brunswick, NJ.
J Clin Gastroenterol. 2019 Feb;53(2):e68-e74. doi: 10.1097/MCG.0000000000000973.
The purpose of our study was to evaluate trends of hospitalization, acute kidney injury (AKI) and mortality in cirrhotic patients with spontaneous bacterial peritonitis (SBP).
SBP is a frequent bacterial infection in cirrhotic patients leading to increased morbidity and mortality.
A total of 4,840,643 patients hospitalized with cirrhosis from 2005 to 2014 were identified using the Nationwide Inpatient Sample database, of which 115,359 (2.4%) had SBP. We examined annual trends and used multivariable mixed-effects logistic regression analyses to obtain adjusted odds ratios by accounting for hospital level and patient level variables.
We identified a striking increase in hospitalizations for SBP in cirrhotic patients (0.45% to 3.12%) and AKI in SBP patients (25.6% to 46.7%) from 2005 to 2014. Inpatient mortality decreased over the study period in patients with SBP (19.1% to 16.1%) and in patients with SBP plus AKI (40.9% to 27.6%). Patients with SBP had a higher inpatient mortality rate than those without SBP [15.5% vs. 6%, adjusted odd ratio (aOR): 2.02, P<0.001]. AKI was 2-fold more prevalent in cirrhotics with SBP than those without SBP (42.8% vs. 17.2%, aOR: 1.91, P<0.001) and concomitant AKI was associated with a 6-fold mortality increase (aOR: 5.84, P<0.001). Cirrhotic patients with SBP had higher hospitalization costs and longer length of stays than patients without SBP.
Despite a higher hospitalization rate and prevalence of concomitant AKI, mortality in patients with SBP decreased during the study period. SBP is associated with high likelihood of development of AKI, which in turn, increases mortality.
本研究旨在评估肝硬化伴自发性细菌性腹膜炎(SBP)患者的住院、急性肾损伤(AKI)和死亡率的趋势。
SBP 是肝硬化患者常见的细菌感染,导致发病率和死亡率增加。
使用全国住院患者样本数据库,确定了 2005 年至 2014 年期间因肝硬化住院的 4840643 例患者,其中 115359 例(2.4%)患有 SBP。我们检查了年度趋势,并使用多变量混合效应逻辑回归分析,通过考虑医院和患者水平的变量,获得调整后的优势比。
我们发现,2005 年至 2014 年期间,肝硬化伴 SBP 患者的住院率(0.45%至 3.12%)和 SBP 患者的 AKI 发生率(25.6%至 46.7%)显著增加。研究期间,SBP 患者(19.1%至 16.1%)和 SBP 合并 AKI 患者(40.9%至 27.6%)的住院死亡率下降。SBP 患者的住院死亡率高于无 SBP 患者[15.5%比 6%,调整后的优势比(aOR):2.02,P<0.001]。SBP 肝硬化患者的 AKI 患病率比无 SBP 患者高两倍(42.8%比 17.2%,aOR:1.91,P<0.001),同时合并 AKI 与死亡率增加 6 倍相关(aOR:5.84,P<0.001)。SBP 肝硬化患者的住院费用和住院时间均高于无 SBP 患者。
尽管 SBP 患者的住院率和合并 AKI 的患病率较高,但在研究期间死亡率下降。SBP 与 AKI 的发生高度相关,进而增加死亡率。